Searle partners with China's Mabwell to sell Denosumab Biosimilars drugs in Pakistan - Markets
Searle Company Limited (Searle) has entered into a license agreement with China’s Mabwell Pharmaceuticals, under...
Source: brecorder.com
Datao Liu News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Datao Liu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Datao Liu Today - Breaking & Trending Today
The World's Second Approved Biosimilars of Denosumab (MAILISHU)
/PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for...
Source: prnewswire.com
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries
/PRNewswire/ -- Mabwell Bioscience (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, today announced the company...
Source: prnewswire.com
Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection
Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection
Source: investegate.co.uk
Junshi Biosciences Announces Approval of Supplemental
SHANGHAI, China, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading...
Source: globenewswire.com